Klotho Neurosciences
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell KLTO and other ETFs, options, and stocks.About KLTO
Klotho Neurosciences, Inc. engages in the provision of new therapies to treat neurodegenerative diseases. It offers cell and gene therapy.
CEOJoseph Sinkule
CEOJoseph Sinkule
Employees3
Employees3
HeadquartersOmaha, Nebraska
HeadquartersOmaha, Nebraska
Founded2004
Founded2004
Employees3
Employees3
KLTO Key Statistics
Market cap26.64M
Market cap26.64M
Price-Earnings ratio-1.11
Price-Earnings ratio-1.11
Dividend yield—
Dividend yield—
Average volume731.60K
Average volume731.60K
High today$0.3683
High today$0.3683
Low today$0.345
Low today$0.345
Open price$0.35
Open price$0.35
Volume417.97K
Volume417.97K
52 Week high$3.91
52 Week high$3.91
52 Week low$0.1135
52 Week low$0.1135
Stock Snapshot
With a market cap of 26.64M, Klotho Neurosciences(KLTO) trades at $0.35. The stock has a price-to-earnings ratio of -1.11.
On 2025-12-25, Klotho Neurosciences(KLTO) stock traded between a low of $0.35 and a high of $0.37. Shares are currently priced at $0.35, which is +2.1% above the low and -4.4% below the high.
The Klotho Neurosciences(KLTO)'s current trading volume is 417.97K, compared to an average daily volume of 731.6K.
In the last year, Klotho Neurosciences(KLTO) shares hit a 52-week high of $3.91 and a 52-week low of $0.11.
In the last year, Klotho Neurosciences(KLTO) shares hit a 52-week high of $3.91 and a 52-week low of $0.11.
People also own
Based on the portfolios of people who own KLTO. This list is generated using Robinhood data, and it’s not a recommendation.